206 related articles for article (PubMed ID: 19328697)
1. Alkenyl substituted bicyclic nucleoside analogues retain nanomolar potency against Varicella Zoster Virus.
McGuigan C; Bidet O; Derudas M; Andrei G; Snoeck R; Balzarini J
Bioorg Med Chem; 2009 Apr; 17(8):3025-7. PubMed ID: 19328697
[TBL] [Abstract][Full Text] [Related]
2. Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): effect of terminal unsaturation in the side-chain.
Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):763-6. PubMed ID: 11563111
[TBL] [Abstract][Full Text] [Related]
3. Bicyclic anti-VZV nucleosides: thieno analogues bearing an alkylphenyl side chain have reduced antiviral activity.
Angell A; McGuigan C; Garcia Sevillano L; Snoeck R; Andrei G; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 2004 May; 14(10):2397-9. PubMed ID: 15109620
[TBL] [Abstract][Full Text] [Related]
4. Bicyclic nucleoside inhibitors of Varicella-Zoster virus: the effect of branching in the p-alkylphenyl side chain.
Luoni G; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 2005 Aug; 15(16):3791-6. PubMed ID: 15993062
[TBL] [Abstract][Full Text] [Related]
5. Bicyclic nucleoside inhibitors of Varicella-Zoster Virus (VZV): the effect of terminal unsaturation in the side chain.
Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 2001 Feb; 11(3):391-3. PubMed ID: 11212118
[TBL] [Abstract][Full Text] [Related]
6. Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain.
McGuigan C; Barucki H; Carangio A; Blewett S; Andrei G; Snoeck R; De Clercq E; Balzarini J; Erichsen JT
J Med Chem; 2000 Dec; 43(26):4993-7. PubMed ID: 11150169
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines.
Migliore MD; Zonta N; McGuigan C; Henson G; Andrei G; Snoeck R; Balzarini J
J Med Chem; 2007 Dec; 50(26):6485-92. PubMed ID: 18052321
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and pharmacological characteristics of the bicyclic nucleoside analogues (BCNAs) as highly selective inhibitors of varicella-zoster virus (VZV).
Sienaert R; Naesens L; Brancale A; Carangio A; Andrei G; Snoeck R; Van Kuilenburg A; De Clercq E; McGuigan C; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):995-7. PubMed ID: 14565329
[No Abstract] [Full Text] [Related]
9. Bicyclic nucleoside inhibitors of varicella-zoster virus: synthesis and biological evaluation of 2',3'-dideoxy-3'-fluoro and 2'-deoxy-xylo derivatives.
Carangio A; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):935-7. PubMed ID: 14565315
[No Abstract] [Full Text] [Related]
10. Bicyclic furo pyrimidine nucleosides with aryloxyphenyl and halophenyl substituted side chains as potent and selective varicella-zoster virus inhibitors.
Blewett S; McGuigan C; Barucki H; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1063-6. PubMed ID: 11562959
[TBL] [Abstract][Full Text] [Related]
11. Halophenyl furanopyrimidines as potent and selective anti-VZV agents.
McGuigan C; Jukes A; Blewett S; Barucki H; Erichsen JT; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2003 May; 14(3):165-70. PubMed ID: 14521333
[TBL] [Abstract][Full Text] [Related]
12. Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base.
McGuigan C; Yarnold CJ; Jones G; Velázquez S; Barucki H; Brancale A; Andrei G; Snoeck R; De Clercq E; Balzarini J
J Med Chem; 1999 Nov; 42(22):4479-84. PubMed ID: 10579812
[TBL] [Abstract][Full Text] [Related]
13. Anti-varicella-zoster virus bicyclic nucleosides: replacement of furo by pyrro base reduces antiviral potency.
McGuigan C; Pathirana RN; Jones G; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2000 Sep; 11(5):343-8. PubMed ID: 11142633
[TBL] [Abstract][Full Text] [Related]
14. Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): Pd-catalysed synthesis of 5-aryl derivatives and their biological evaluation.
Carangio A; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2001 May; 12(3):187-97. PubMed ID: 12959327
[TBL] [Abstract][Full Text] [Related]
15. New conformationally locked bicyclic N,O-nucleoside analogues of antiviral drugs.
Procopio A; Alcaro S; De Nino A; Maiuolo L; Ortuso F; Sindona G
Bioorg Med Chem Lett; 2005 Feb; 15(3):545-50. PubMed ID: 15664810
[TBL] [Abstract][Full Text] [Related]
16. 2'-Fluorosugar analogues of the highly potent anti-varicella-zoster virus bicyclic nucleoside analogue (BCNA) Cf 1743.
McGuigan C; Derudas M; Quintiliani M; Andrei G; Snoeck R; Henson G; Balzarini J
Bioorg Med Chem Lett; 2009 Nov; 19(22):6264-7. PubMed ID: 19833513
[TBL] [Abstract][Full Text] [Related]
17. Novel aryl substituted bicyclic furo nucleosides as extremely potent and selective anti-VZV agents.
McGuigan C; Barucki H; Carangio A; Blewett S; Srinivasan S; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):287-96. PubMed ID: 11563040
[No Abstract] [Full Text] [Related]
18. Bicyclic nucleoside inhibitors of varicella-zoster virus modified on the sugar moiety: 3' and 5' derivatives.
Luoni GM; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2004 Nov; 15(6):333-41. PubMed ID: 15646647
[TBL] [Abstract][Full Text] [Related]
19. Bicyclic nucleoside inhibitors of varicella-zoster virus: 5'-chloro and 3'-chloro derivatives.
Luoni G; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):931-3. PubMed ID: 14565314
[TBL] [Abstract][Full Text] [Related]
20. Emimycin and its nucleoside derivatives: Synthesis and antiviral activity.
Plebanek E; Lescrinier E; Andrei G; Snoeck R; Herdewijn P; De Jonghe S
Eur J Med Chem; 2018 Jan; 144():93-103. PubMed ID: 29268134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
